×

Boris Johnson Defends AstraZeneca Shot Over Blood Clot Fears

    Advertisement British Prime Minister Boris Johnson on Tuesday defended the safety of the AstraZeneca coronavirus vaccine after several European countries halted its rollout … Continue reading Boris Johnson Defends AstraZeneca Shot Over Blood Clot Fears


Britain’s Prime Minister Boris Johnson gestures as he holds a remote press conference to update the nation on the post-Brexit trade agreement, inside 10 Downing Street in central London on December 24, 2020. – Britain said on Thursday, December 24, 2020 an agreement had been secured on the country’s future relationship with the European Union, after last-gasp talks just days before a cliff-edge deadline. (Photo by Paul GROVER / POOL / AFP)
Britain’s Prime Minister Boris Johnson gestures as he holds a remote press conference to update the nation on the post-Brexit trade agreement, i(Photo by Paul GROVER / POOL / AFP)

 

 

British Prime Minister Boris Johnson on Tuesday defended the safety of the AstraZeneca coronavirus vaccine after several European countries halted its rollout over blood clot fears.

Germany, Italy and France on Monday joined others in suspending the vaccine, dealing a potential blow to the global immunisation campaign against a disease that has killed more than 2.6 million people.

However, the World Health Organization, AstraZeneca, and the European Medicines Agency have insisted the shot is safe, and that there is no link between it and reported blood clots.

The British leader on Tuesday echoed assurances that the jab was not harmful.

“That vaccine is safe and works extremely well,” Johnson wrote in The Times newspaper.

In this file photo taken on March 12, 2021, shows empty vials of the AstraZeneca Covid-19 vaccine at a vaccination Fred TANNEAU / AFP

 

“It is being made in multiple places from India to the US, as well as Britain, and it is being used around the world,” he added.

Fears have grown in some countries over the safety of the AstraZeneca vaccine after several cases of blood clots or brain haemorrhages in people after receiving the inoculation, with a small number of deaths reported.

But AstraZeneca and medical experts in Britain have said there is no evidence of clots being caused by the jab or that they are occurring in greater numbers or frequency than in the general population.

The vaccine was developed by AstraZeneca and the University of Oxford in Britain, where more than 11 million doses have been administered, without any major problems reported.

On Monday, Johnson told reporters that Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) is “one of the toughest and most experienced regulators in the world”.

“They see no reason at all to discontinue the vaccination programme… for either of the vaccines that we’re currently using,” he said.

“They believe that they are highly effective in driving down not just hospitalisation but also serious disease and mortality.

“We continue to be very confident about the programme and it’s great to see it being rolled out at such speed across the UK.”